Ionis Historical Balance Sheet

IONS Stock  USD 35.90  0.53  1.50%   
Trend analysis of Ionis Pharmaceuticals balance sheet accounts such as Other Current Liabilities of 226.4 M or Total Current Liabilities of 470.5 M provides information on Ionis Pharmaceuticals' total assets, liabilities, and equity, which is the actual value of Ionis Pharmaceuticals to its prevalent stockholders. By breaking down trends over time using Ionis Pharmaceuticals balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Ionis Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Ionis Pharmaceuticals is a good buy for the upcoming year.

Ionis Pharmaceuticals Inventory

29.85 Million

  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ionis Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Ionis Stock please use our How to Invest in Ionis Pharmaceuticals guide.

About Ionis Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Ionis Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. Ionis Pharmaceuticals Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Ionis Pharmaceuticals and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Ionis currently owns. An asset can also be divided into two categories, current and non-current.

Ionis Pharmaceuticals Balance Sheet Chart

At this time, Ionis Pharmaceuticals' Cash And Short Term Investments are comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 3.1 B in 2024, despite the fact that Retained Earnings are likely to grow to (1.7 B).

Total Assets

Total assets refers to the total amount of Ionis Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Ionis Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Ionis Pharmaceuticals balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Ionis Pharmaceuticals are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.
Most accounts from Ionis Pharmaceuticals' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Ionis Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ionis Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Ionis Stock please use our How to Invest in Ionis Pharmaceuticals guide.At this time, Ionis Pharmaceuticals' Cash And Short Term Investments are comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 3.1 B in 2024, despite the fact that Retained Earnings are likely to grow to (1.7 B).
 2021 2022 2023 2024 (projected)
Short and Long Term Debt Total1.2B1.3B1.5B1.5B
Total Assets2.6B2.5B3.0B3.1B

Ionis Pharmaceuticals balance sheet Correlations

0.870.580.920.730.86-0.16-0.60.680.940.61.00.590.930.960.940.931.00.30.740.520.50.830.960.430.64
0.870.720.930.340.960.21-0.80.410.690.170.870.490.980.920.840.980.890.230.740.510.590.970.840.40.32
0.580.720.650.110.640.36-0.530.110.540.20.570.220.690.550.510.690.58-0.460.410.420.350.70.560.230.22
0.920.930.650.430.930.18-0.80.40.790.330.910.50.970.930.90.980.930.340.720.670.610.910.910.430.33
0.730.340.110.430.38-0.75-0.040.90.830.870.730.590.430.610.660.430.70.240.50.180.090.260.670.320.86
0.860.960.640.930.380.17-0.840.430.720.180.860.570.940.910.890.940.880.320.810.50.490.940.850.520.25
-0.160.210.360.18-0.750.17-0.38-0.8-0.31-0.62-0.17-0.40.17-0.05-0.160.17-0.14-0.09-0.110.090.30.33-0.1-0.13-0.64
-0.6-0.8-0.53-0.8-0.04-0.84-0.38-0.12-0.420.12-0.6-0.62-0.78-0.64-0.76-0.78-0.62-0.27-0.8-0.7-0.47-0.81-0.54-0.710.07
0.680.410.110.40.90.43-0.8-0.120.720.690.690.660.440.610.660.430.670.230.530.230.090.280.610.350.79
0.940.690.540.790.830.72-0.31-0.420.720.810.930.570.780.830.870.780.920.160.660.480.310.640.910.420.72
0.60.170.20.330.870.18-0.620.120.690.810.590.360.30.410.480.30.56-0.030.260.250.020.10.570.160.83
1.00.870.570.910.730.86-0.17-0.60.690.930.590.60.930.960.940.931.00.30.740.520.490.830.950.430.65
0.590.490.220.50.590.57-0.4-0.620.660.570.360.60.490.510.770.490.590.20.880.530.130.420.460.860.38
0.930.980.690.970.430.940.17-0.780.440.780.30.930.490.950.881.00.940.280.730.560.610.960.890.390.4
0.960.920.550.930.610.91-0.05-0.640.610.830.410.960.510.950.90.950.970.40.720.440.570.890.950.340.53
0.940.840.510.90.660.89-0.16-0.760.660.870.480.940.770.880.90.890.940.350.880.640.450.80.870.690.51
0.930.980.690.980.430.940.17-0.780.430.780.30.930.491.00.950.890.940.290.730.580.610.960.90.40.39
1.00.890.580.930.70.88-0.14-0.620.670.920.561.00.590.940.970.940.940.320.750.520.530.850.950.420.62
0.30.23-0.460.340.240.32-0.09-0.270.230.16-0.030.30.20.280.40.350.290.320.290.10.330.240.330.11-0.01
0.740.740.410.720.50.81-0.11-0.80.530.660.260.740.880.730.720.880.730.750.290.520.290.720.640.810.34
0.520.510.420.670.180.50.09-0.70.230.480.250.520.530.560.440.640.580.520.10.520.330.430.470.560.1
0.50.590.350.610.090.490.3-0.470.090.310.020.490.130.610.570.450.610.530.330.290.330.570.480.040.1
0.830.970.70.910.260.940.33-0.810.280.640.10.830.420.960.890.80.960.850.240.720.430.570.810.390.28
0.960.840.560.910.670.85-0.1-0.540.610.910.570.950.460.890.950.870.90.950.330.640.470.480.810.290.57
0.430.40.230.430.320.52-0.13-0.710.350.420.160.430.860.390.340.690.40.420.110.810.560.040.390.290.15
0.640.320.220.330.860.25-0.640.070.790.720.830.650.380.40.530.510.390.62-0.010.340.10.10.280.570.15
Click cells to compare fundamentals

Ionis Pharmaceuticals Account Relationship Matchups

Ionis Pharmaceuticals balance sheet Accounts

201920202021202220232024 (projected)
Total Assets3.2B2.4B2.6B2.5B3.0B3.1B
Short Long Term Debt Total772.0M808.9M1.2B1.3B1.5B1.5B
Other Current Liab136.9M(128.4M)127.6M189.3M215.6M226.4M
Total Current Liabilities273M290M241M312M448.1M470.5M
Total Stockholder Equity1.5B843M772M573M386.7M265.7M
Property Plant And Equipment Net154M181M178M256M242.9M255.1M
Net Debt(1.8B)(1.1B)(954M)(642M)1.1B1.1B
Retained Earnings(707.5M)(1.2B)(1.2B)(1.4B)(1.8B)(1.7B)
Cash2.5B1.9B2.1B2.0B399.3M534.5M
Non Current Assets Total512M260M267M331M348.2M365.6M
Non Currrent Assets Other358M51.1M60.0M34.6M62.3M34.5M
Cash And Short Term Investments2.5B1.9B2.1B2.0B2.3B2.4B
Common Stock Shares Outstanding142.9M139.6M141.0M141.8M143.2M83.9M
Liabilities And Stockholders Equity3.2B2.4B2.6B2.5B3.0B3.1B
Non Current Liabilities Total1.3B1.3B1.6B1.6B2.2B2.3B
Other Current Assets158M162M168M157.7M184.4M193.7M
Other Stockholder Equity2.2B2.1B2.0B2.1B2.2B2.3B
Total Liab1.5B1.5B1.8B2.0B2.6B2.7B
Total Current Assets2.7B2.1B2.3B2.2B2.6B2.8B
Short Term Debt2.0M293.2M3.5M7.5M53.2M55.8M
Intangible Assets24.0M25.7M27.9M29.0M33.4M24.2M
Accounts Payable16.1M17.2M11.9M17.9M26.0M27.3M
Net Receivables63M76M62M25.5M97.8M102.7M
Property Plant And Equipment Gross153.7M181.1M280.7M256M339.7M356.7M
Accumulated Other Comprehensive Income(25.3M)(21.1M)(32.7M)(57.5M)(32.6M)(31.0M)
Short Term Investments1.8B1.5B1.2B1.7B1.9B2.0B
Other Assets310.6M78.0M319M35.0M40.2M57.3M
Long Term Debt770.0M515.7M1.2B1.2B1.2B1.3B
Property Plant Equipment153.7M181.1M178.1M74.3M85.4M79.6M
Other Liab490.1M424M352M287.8M330.9M170.0M
Current Deferred Revenue118M108M98M91M151.1M158.7M
Inventory18.2M22.0M24.8M22.0M28.4M29.8M
Net Tangible Assets1.4B815.4M742.7M572.9M658.8M531.9M
Retained Earnings Total Equity(707.5M)(1.2B)(1.2B)(1.4B)(1.3B)(1.4B)
Long Term Debt Total770.0M515.7M1.2B1.2B1.4B1.4B
Capital Surpluse2.2B2.1B2.0B2.1B2.4B1.7B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Ionis Stock Analysis

When running Ionis Pharmaceuticals' price analysis, check to measure Ionis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ionis Pharmaceuticals is operating at the current time. Most of Ionis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ionis Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ionis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ionis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.